Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
mifepristone
Regulatory
SCOTUS sides 9-0 with FDA, rejects mifepristone challenge
An undivided court ruled that anti-abortion doctors who brought the case are not harmed by the abortion drug's regulatory availability.
Dave Muoio
Jun 13, 2024 10:51am
SCOTUS appears unwilling to limit abortion pill nationwide
Mar 26, 2024 1:48pm
What's at stake in the SCOTUS mifepristone case
Mar 25, 2024 6:00pm
Study: Telehealth medication abortions effective, safe
Feb 16, 2024 3:15pm
Biden admin warns SCOTUS against restricting abortion pill
Jan 24, 2024 10:22am
Judge suspends FDA approval of abortion pill
Apr 7, 2023 7:37pm
